ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Barcelona, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Overweight

Diabetes trials near Barcelona, CT, ESP:

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (DIAGNODE-3)

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Barcelona, Spain and 59 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Barcelona, Spain and 78 other locations

This study will look at the effects of CagriSema in people with both type 2 diabetes and painful diabetic peripheral neuropathy, co...

Enrolling
Diabetes Mellitus, Type 2
Diabetic Peripheral Neuropathy
Drug: CagriSema (Cagrilintide B and Semaglutide I)
Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Phase 2

Novo Nordisk
Novo Nordisk

Barcelona, Spain and 54 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Barcelona, Spain and 227 other locations

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: AZD5004
Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca
AstraZeneca

Barcelona, Spain and 96 other locations

The purpose of this study is to find out if baricitinib can delay the onset of clinical type 1 diabetes (T1D) in people who are at high risk...

Begins enrollment this month
Diabetes Mellitus, Type 1
Drug: Baricitinib
Drug: Placebo

Phase 3

Lilly
Lilly

Esplugues de Llobregat, Spain and 105 other locations

The main purpose of this study is to find out how well and how safely tirzepatide works long-term in adults who have type 1 diabetes and obe...

Enrolling
Type 1 Diabetes
Overweight
Drug: Placebo
Drug: Tirzepatide

Phase 3

Lilly
Lilly

Barcelona, Spain and 78 other locations

Phase II study aims to evaluate the efficacy, tolerability, and safety of RO7795081 for glycemic control in adult participants with Type 2 diabetes...

Enrolling
Type 2 Diabetes Mellitus
Drug: Semaglutide
Drug: Placebo

Phase 2

Roche
Roche

Barcelona, Spain and 46 other locations

The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or ov...

Enrolling
Type 1 Diabetes
Overweight
Drug: Tirzepatide
Drug: Placebo

Phase 3

Lilly
Lilly

Barcelona, Spain and 146 other locations

medical purpose population, i.e., in individuals with unknown diabetes risk. Additionally, this investigation will serve as a pivotal perfor...

Active, not recruiting
Pre-diabetes
Undiagnosed Diseases
Device: Near-infrared (NIR)
Glyconics

Barcelona, Spain

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems